Showing results (1241-1250 of 1,437) with videos related to
Sort By:
Pageof 144
Nature Communications|November 26, 2014
ERG induces taxane resistance in castration-resistant prostate cancerGiuseppe Galletti, Alexandre Matov, Himisha Beltran, et al.European Urology|September 2, 2023
Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer ProgressionAlexandros Papachristodoulou, Isabel Heidegger, Renu K Virk, et al.Nature|August 31, 2018
Publisher Correction: Suppression of insulin feedback enhances the efficacy of PI3K inhibitorsBenjamin D Hopkins, Chantal Pauli, Xing Du, et al.Peptides|October 6, 2009
Endogenous opioid peptide responses to opioid and anti-inflammatory medications following eccentric exercise-induced muscle damageWilliam J Kraemer, Michael F Joseph, Jeff S Volek, et al.Nature Medicine|December 28, 2004
Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsuleSandra M Gaston, Marc A Soares, M Minhaj Siddiqui, et al.Cancer Cell|April 2, 2019
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate TumorigenesisMichael A Augello, Deli Liu, Lesa D Deonarine, et al.Veterinary Medicine and Science|October 10, 2021
Comparative pathology of dog and human prostate cancerToby Ryman-Tubb, Jennifer H Lothion-Roy, Veronika M Metzler, et al.Neoplasia (New York, N.Y.)|October 28, 2008
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancerSooryanarayana Varambally, Bharathi Laxman, Rohit Mehra, et al.Elife|September 17, 2015
SPOP mutation leads to genomic instability in prostate cancerGunther Boysen, Christopher E Barbieri, Davide Prandi, et al.Cancer Research|May 1, 2002
Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugateSarajane Ross, Susan D Spencer, Ilona Holcomb, et al.Pageof 144